Abstracts - faqs.org

Abstracts

Business, international

Search abstracts:
Abstracts » Business, international

Critics pan Springer's merger plan

Article Abstract:

The planned merger of Axel Springer AG of Germany and ProSiebenSat.1 Media AG of Germany is facing heat from critics. The merger of Germany's newspaper publishing giant and the television broadcasting interest for approximately 4.32 billion Euros ($5.17 billion) is being interpreted as a cause for concern as the acquisition could be an antitrust issue, putting a choke hold on competition.

Author: Karnitschnig, Matthew
Publisher: Dow Jones Publishing Co. (Europe)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2005

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Springer to buy broadcaster ProSieben for $3.01 billion

Article Abstract:

Axel Springer AG of Germany is to acquire ProSiebenSat.1 Media AG of Germany for 2.47 billion Euros ($3.01 billion). The deal would nearly double the leading German newspaper publishing company's value to 4.2 billion Euros.

Author: Karnitschnig, Matthew, Singer, Jason
Publisher: Dow Jones Publishing Co. (Europe)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2005

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA



Subjects list: Germany, Mergers, acquisitions and divestments, Television broadcasting industry, Company acquisition/merger, Newspaper publishing, ProSiebenSat.1 Media AG
Similar abstracts:
  • Abstracts: Novartis offers to buy rest of Chiron. Novartis agrees to acquire the rest of Chiron for $5.1 billion. Biotech industry heads toward IPO boomlet
  • Abstracts: Japan's election, set for Nov.9, could speed economic changes. Drop in Japanese bond prices fails to frighten economists
  • Abstracts: Bill to aid tobacco farmers hinges on a windfall for landowners
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.